4//SEC Filing
Banks Jerel A. 4
Accession 0001062993-24-005970
CIK 0001808898other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:13 PM ET
Size
5.1 KB
Accession
0001062993-24-005970
Insider Transaction Report
Form 4
Banks Jerel A.
DirectorChief Executive Officer
Transactions
- Award
Options (right to buy)
2024-03-06+466,554→ 466,554 totalExercise: $5.21Exp: 2034-03-06→ Common Stock (466,554 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808930
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:13 PM ET
- Size
- 5.1 KB